If you have recently tested positive for COVID-19, you may be eligible for a study.
The H051 Study is title Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients’. It is listed in the national clearinghouse for clinical trials (ClinicalTrials.gov) as NCT04360551.